General

• Schering-Plough's website

Financial

• Sales and Earnings for 2000 4th Quarter and Full Year. Schering-Plough press release, January 25, 2000.
• SEC 10-K Annual Financial Filing. Contains sales figures and patent expiration dates for the company's ten largest selling drugs, firm-level R&D figures, information on lawsuits filed against the firm, income and cost data, stock information, financial holdings, and a complete list of BMS's subsidiaries.
• Notice of 2000 Annual Meeting and Proxy Statement. Contains exececutive compensation figures, including salaries and stock options.
• Out going CEO Richard J. Kogan's salary and stock options from the AFL-CIO's page on executive compensation. Also, see a more detailed breakdown of his executive compensation and severence package from Business.com.

• Soft Money Donations in the 1999-2000 Election Cycle Source: Center for Responsive Politics, www.opensecrets.org
• PAC Contributions to Federal Candidates in the 1999-2000 Election Cycle Source: Center for Responsive Politics, www.opensecrets.org
• Lobbying Expenditures in 1998 Source: Center for Responsive Politics, www.opensecrets.org

Drugs Related to IPR Disputes

• Claritin

  Schering-Plough's patent on Claritin is set to expire in 2002. According to SEC filings, Schering-Plough made $2.7 billion in sales of Claritin in 1999, and $2.3 billion in 1998. In order to prevent competition from generics when the patent expires, the company has been lobbying hard for an extention of patent rights.

  • January 10, 2001, Reuters. Impax says sued by Schering-Plough over Claritin
  • June 26, 2000. Paul Kane in Roll Call. Hatch Admits He's 'Senator Anonymous'
  • June 24, 2000. Jackie Judd and Carter M. Yang for ABC News. 'Senator Anonymous' Revealed.
  • July 29, 1999. Public Citizen. Can Schering-Plough's Aggressive Lobbying Buy a Patent Extention?

• K-Dur 20
  • April 26, 2001. Shannon P. Duffy for Law.com. Schering-Plough Accused of 'Sham' Settlement to Postpone Generics.

• May 30, 2003. Judy Bocklage for Dow Jones Newswire. Schering-Plough Says Govt Pursuing Indictment.

MAIN OFFICE
2000 Galloping Hill Road
Kenilworth, N.J. 07033-0530
(tel) 908-298-4000

WASHINGTON, DC OFFICE
Scgering-Plough Legislative Resources, LLC
1130 Connecticut Ave., NW # 500
Washington, DC, 20036
(tel) 202-463-7372
(fax) 202-463-8809
Richard J. Kinney, Staff V.P., Public Affiars